We are live on ! Find out more
BFM

Boston Financial Management Portfolio holdings

AUM $3.31B
1-Year Est. Return 19.4%
This Fund
S&P 500
This Quarter Est. Return
+4.04%
1 Year Est. Return
+19.4%
3 Year Est. Return
+30.07%
5 Year Est. Return
+107.8%
10 Year Est. Return
+274.5%
AUM
$758M
AUM Growth
+$10.8M
Cap. Flow
-$14.1M
Cap. Flow %
-1.86%
Top 10 Hldgs %
25.76%
Holding
210
New
11
Increased
76
Reduced
102
Closed
7

Top Buys

Rank Stock Value
1
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$1.43M
2
V icon
Visa
V
+$1.2M
3
WFM
Whole Foods Market Inc
WFM
+$1.18M
4
RL icon
Ralph Lauren
RL
+$960K
5
CTSH icon
Cognizant
CTSH
+$891K

Top Sells

Rank Stock Value
1
IBM icon
IBM
IBM
+$5.96M
2
IJH icon
iShares Core S&P Mid-Cap ETF
IJH
+$2.44M
3
XOM icon
ExxonMobil
XOM
+$2.29M
4
ABBV icon
AbbVie
ABBV
+$2.07M
5
IJR icon
iShares Core S&P Small-Cap ETF
IJR
+$1.88M

Sector Composition

Rank Sector Weight
1 Healthcare 22.8%
2 Energy 11.9%
3 Industrials 11.23%
4 Consumer Staples 10.78%
5 Technology 9.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PFE icon
1
Pfizer
PFE
$142B
$62.4M 8.24%
2,217,183
-59,695
-3% -$1.7M
XOM icon
2
ExxonMobil
XOM
$651B
$22.5M 2.97%
223,389
-22,730
-9% -$2.29M
JNJ icon
3
Johnson & Johnson
JNJ
$617B
$18.5M 2.44%
176,571
-422
-0.2% -$42.7K
ABBV icon
4
AbbVie
ABBV
$455B
$15.5M 2.04%
273,968
-39,540
-13% -$2.07M
EMR icon
5
Emerson Electric
EMR
$83.3B
$14.7M 1.93%
220,937
-3,987
-2% -$268K
ADP icon
6
Automatic Data Processing
ADP
$105B
$13.5M 1.78%
193,828
-1,959
-1% -$134K
APC
7
DELISTED
Anadarko Petroleum
APC
$12.5M 1.65%
114,367
-3,135
-3% -$319K
PG icon
8
Procter & Gamble
PG
$335B
$12.4M 1.63%
157,539
-5,023
-3% -$405K
GE icon
9
GE Aerospace
GE
$368B
$11.8M 1.56%
93,586
-82
-0.1% -$10.4K
AAPL icon
10
Apple
AAPL
$4.9T
$11.5M 1.52%
495,912
-80
-0% -$1.7K
UNP icon
11
Union Pacific
UNP
$172B
$11.2M 1.48%
112,231
+4,651
+4% +$451K
MSFT icon
12
Microsoft
MSFT
$3.35T
$11.1M 1.47%
266,301
+3,118
+1% +$126K
SLB icon
13
SLB Ltd
SLB
$72.6B
$11.1M 1.46%
93,897
-655
-0.7% -$67.5K
AXP icon
14
American Express
AXP
$228B
$10.9M 1.44%
115,168
-80
-0.1% -$7.21K
CVS icon
15
CVS Health
CVS
$134B
$10.1M 1.33%
133,387
+1,640
+1% +$124K
ABT icon
16
Abbott
ABT
$183B
$9.84M 1.3%
240,529
-26,244
-10% -$1.03M
MMM icon
17
3M
MMM
$90.8B
$9.57M 1.26%
79,898
-772
-1% -$90.6K
DEO icon
18
Diageo
DEO
$49.5B
$9.09M 1.2%
71,402
+2,635
+4% +$332K
PEP icon
19
PepsiCo
PEP
$191B
$8.7M 1.15%
97,382
-2,238
-2% -$193K
MRK icon
20
Merck
MRK
$321B
$8.69M 1.15%
157,358
+3,799
+2% +$207K
GOOG icon
21
Alphabet (Google) Class C
GOOG
$4.08T
$8.21M 1.08%
283,917
-1,710
-0.6% -$46.4K
WFC icon
22
Wells Fargo
WFC
$258B
$8.15M 1.08%
155,138
+8,936
+6% +$449K
CAT icon
23
Caterpillar
CAT
$373B
$7.96M 1.05%
73,247
+1,638
+2% +$172K
APD icon
24
Air Products & Chemicals
APD
$66.8B
$7.91M 1.04%
66,439
+737
+1% +$82.2K
IBM icon
25
IBM
IBM
$209B
$7.9M 1.04%
45,591
-33,134
-42% -$5.96M
1
2 3 4 5

Similar funds

CANY
Caxton Associates (New York) New York $3.18B AUM 54.49% 1-Year Est. Return
MWM
Merriman Wealth Management Seattle, Washington $2.4B AUM 13.66% 1-Year Est. Return
CCM
Carlson Capital Management Northfield, Minnesota $2.29B AUM 7.48% 1-Year Est. Return
ECG
Edge Capital Group Atlanta, Georgia $2.24B AUM 19.7% 1-Year Est. Return
LSAG
Lake Street Advisors Group Portsmouth, New Hampshire $2.17B AUM 16.99% 1-Year Est. Return
KL
KGH Ltd Nassau, Bahamas $1.92B AUM 13.96% 1-Year Est. Return
WP
WMS Partners Towson, Maryland $1.78B AUM 11.82% 1-Year Est. Return
RDIA
RE Dickinson Investment Advisors Council Bluffs, Iowa $1.77B AUM 15.45% 1-Year Est. Return

Boston Financial Management's Q2 2014 Portfolio in Review

As of Q2 2014, Boston Financial Management held 210 positions worth $758M, up 1.5% from $747M the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Boston Financial Management's Q2 2014 filing shows 11 new, 76 increased, 102 reduced and 7 closed positions. Its largest new stake was Theravance Biopharma: 16,982 shares worth $541K. The largest sale was IBM, an estimated $5.96M.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 24% a quarter earlier, followed by Energy and Industrials.

  • Boston Financial Management's largest Q2 2014 buy was Theravance Biopharma: 16,982 shares worth $541K.
  • Boston Financial Management added most to Berkshire Hathaway Class B in Q2 2014, an estimated $1.43M increase.
  • Boston Financial Management's biggest Q2 2014 reduction was IBM, cutting an estimated $5.96M.
  • Boston Financial Management fully exited Vanguard Morningstar Total Stock Market ETF in Q2 2014, selling an estimated $1.38M.
  • Boston Financial Management's ten largest holdings make up 26% of its $758M portfolio in Q2 2014.
  • Boston Financial Management opened 11 new positions and closed 7 in Q2 2014.
  • Boston Financial Management's portfolio value rose 1.5% quarter-over-quarter to $758M.

Based on Boston Financial Management's 13F filing for Q2 2014, filed 20 Aug 2014.